| The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation O Anczuków, AZ Rosenberg, M Akerman, S Das, L Zhan, R Karni, ... Nature structural & molecular biology 19 (2), 220-228, 2012 | 458 | 2012 |
| IL35-producing B cells promote the development of pancreatic neoplasia Y Pylayeva-Gupta, S Das, JS Handler, CH Hajdu, M Coffre, SB Koralov, ... Cancer discovery 6 (3), 247-255, 2016 | 304 | 2016 |
| Emerging functions of SRSF1, splicing factor and oncoprotein, in RNA metabolism and cancer S Das, AR Krainer Molecular Cancer Research 12 (9), 1195-1204, 2014 | 289 | 2014 |
| Tumor cell–derived IL1β promotes desmoplasia and immune suppression in pancreatic cancer S Das, B Shapiro, EA Vucic, S Vogt, D Bar-Sagi Cancer research 80 (5), 1088-1101, 2020 | 236 | 2020 |
| Oncogenic splicing factor SRSF1 is a critical transcriptional target of MYC S Das, O Anczuków, M Akerman, AR Krainer Cell reports 1 (2), 110-117, 2012 | 220 | 2012 |
| Splicing-factor oncoprotein SRSF1 stabilizes p53 via RPL5 and induces cellular senescence OI Fregoso, S Das, M Akerman, AR Krainer Molecular cell 50 (1), 56-66, 2013 | 113 | 2013 |
| Differential functions of splicing factors in mammary transformation and breast cancer metastasis SH Park, M Brugiolo, M Akerman, S Das, L Urbanski, A Geier, ... Cell reports 29 (9), 2672-2688. e7, 2019 | 88 | 2019 |
| Kras and tumor immunity: friend or foe? J Cullis, S Das, D Bar-Sagi Cold Spring Harbor perspectives in medicine 8 (9), a031849, 2018 | 68 | 2018 |
| BTK signaling drives CD1dhiCD5+ regulatory B-cell differentiation to promote pancreatic carcinogenesis S Das, D Bar-Sagi Oncogene 38 (17), 3316-3324, 2019 | 58 | 2019 |
| Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing S Jo, S Das, A Williams, AS Chretien, T Pagliardini, A Le Roy, ... Nature Communications 13 (1), 3453, 2022 | 56 | 2022 |
| IL35-producing B cells promote the development of pancreatic neoplasia. Cancer Discov. 2016; 6: 247–255. doi: 10.1158/2159-8290 Y Pylayeva-Gupta, S Das, JS Handler, CH Hajdu, M Coffre, SB Koralov, ... CD-15-0843.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 52 | |
| Differential connectivity of splicing activators and repressors to the human spliceosome M Akerman, OI Fregoso, S Das, C Ruse, MA Jensen, DJ Pappin, ... Genome biology 16, 1-18, 2015 | 43 | 2015 |
| A new path to oncogene-induced senescence: at the crossroads of splicing and translation S Das, OI Fregoso, AR Krainer Cell Cycle 12 (10), 1477-1479, 2013 | 10 | 2013 |
| Stromal depletion by TALEN-edited universal hypoimmunogenic FAP-CAR T cells enables infiltration and anti-tumor cytotoxicity of tumor antigen-targeted CAR-T immunotherapy S Das, J Valton, P Duchateau, L Poirot Frontiers in Immunology 14, 1172681, 2023 | 5 | 2023 |
| Differential functions of splicing factors in breast-cancer initiation and metastasis S Das, M Akerman, SH Park, M Brugioli, A Geier, AK Kesarwani, M Fan, ... bioRxiv, 634154, 2019 | 2 | 2019 |
| 325 TALEN-edited SMART CAR T-cells leverage solid tumor microenvironment for specific and effective immunotherapy S Das, S Dharani, J Valton, P Duchateau, L Poirot Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| 217 Multi-armored allogeneic MUC-1 CAR T-cells efficiently control triple negative breast cancer tumor growth P Erler, T Kurcon, J Skinner, C Dixon, S Grudman, B Mumford, S Das, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| CAR-T cell engineering strategies aimed at safe and effective targeting of solid tumors S Das, S Dharani, J Valton, P Duchateau, L Poirot European Journal of Cancer 174, S15, 2022 | | 2022 |
| Chen, X.-H., Liu, L., Li, J., Zhang, F.: Role of Ti and Y in the nucleation of the primary α-Al of Al7075–Ti–Y natural composites and influence of ultrasonic vibration … Y Chen, Z Ji, M Hu, H Xu, G Feng, B Dang, Z Jian, J Xu, S Das, RK Singh, ... Int. J. Mater. Res 112 (12), 1001, 2021 | | 2021 |
| Regulation and function of IL-1b in immune modulation of pancreatic cancer. S Das, S Vogt, C Hadju, D Bar-Sagi CANCER IMMUNOLOGY RESEARCH 8 (4), 101-101, 2020 | | 2020 |
